L Tordesillas1, N Cubells-Baeza2, C Gómez-Casado3, C Berin1, V Esteban4, W Barcik5, L O'Mahony5, C Ramirez2,6, L F Pacios2,7, M Garrido-Arandia2, A Díaz-Perales2,6. 1. Icahn School of Medicine at Mount Sinai, New York, NY, USA. 2. Centre for Plant Genomics and Biotechnology (UPM-INIA), Pozuelo de Alarcon, Madrid, Spain. 3. Institute of Applied Molecular Medicine (IMMA), CEU San Pablo University, Boadilla del Monte, Spain. 4. Fundacion Jimenez Díaz, Madrid, Spain. 5. Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland. 6. Department of Biotechnology and Plant Biology, ETSI Agronómica, Alimentaria y de Biosistemas, Technical University of Madrid, Madrid, Spain. 7. Department of Natural Systems and Resources, ETSI Montes, Technical University of Madrid, Madrid, Spain.
Abstract
BACKGROUND: Recently, the nature of the lipid-ligand of Pru p 3, one of the most common plant food allergens in southern Europe, has been identified as a derivative of the alkaloid camptothecin bound to phytosphingosine. However, the origin of its immunological activity is still unknown. OBJECTIVE: We sought to evaluate the role of the Pru p 3 lipid-ligand in the immunogenic activity of Pru p 3. METHODS: In vitro cultures of different cell types (monocyte-derived dendritic cells [moDCs], PBMCs [peripheral blood mononuclear cells] and epithelial and iNKT-hybridoma cell lines) have been used to determine the immunological capacity of the ligand, by measuring cell proliferation, maturation markers and cytokine production. To study the capacity of the lipid-ligand to promote sensitization to Pru p 3 in vivo, a mouse model of anaphylaxis to peach has been produced and changes in the humoral and basophil responses have been analysed. RESULTS: The lipid-ligand of Pru p 3 induced maturation of moDCsc and proliferation of PBMCs. Its immunological activity resided in the phytosphingosine tail of the ligand. The adjuvant activity of the ligand was also confirmed in vivo, where the complex of Pru p 3-ligand induced higher levels of IgE than Pru p 3 alone. The immunological capacity of the Pru p 3 ligand was mediated by CD1d, as maturation of moDCs was inhibited by anti-CD1d antibodies and Pru p 3-ligand co-localized with CD1d on epithelial cells. Finally, Pru p 3-ligand presented by CD1d was able to interact with iNKTs. CONCLUSIONS AND CLINICAL RELEVANCE: The Pru p 3 lipid-ligand could act as an adjuvant to promote sensitization to Pru p 3, through its recognition by CD1d receptors. This intrinsic adjuvant activity of the accompanying lipid cargo could be a general essential feature of the mechanism underlying the phenomenon of allergenicity.
BACKGROUND: Recently, the nature of the lipid-ligand of Pru p 3, one of the most common plant food allergens in southern Europe, has been identified as a derivative of the alkaloid camptothecin bound to phytosphingosine. However, the origin of its immunological activity is still unknown. OBJECTIVE: We sought to evaluate the role of the Pru p 3 lipid-ligand in the immunogenic activity of Pru p 3. METHODS: In vitro cultures of different cell types (monocyte-derived dendritic cells [moDCs], PBMCs [peripheral blood mononuclear cells] and epithelial and iNKT-hybridoma cell lines) have been used to determine the immunological capacity of the ligand, by measuring cell proliferation, maturation markers and cytokine production. To study the capacity of the lipid-ligand to promote sensitization to Pru p 3 in vivo, a mouse model of anaphylaxis to peach has been produced and changes in the humoral and basophil responses have been analysed. RESULTS: The lipid-ligand of Pru p 3 induced maturation of moDCsc and proliferation of PBMCs. Its immunological activity resided in the phytosphingosine tail of the ligand. The adjuvant activity of the ligand was also confirmed in vivo, where the complex of Pru p 3-ligand induced higher levels of IgE than Pru p 3 alone. The immunological capacity of the Pru p 3 ligand was mediated by CD1d, as maturation of moDCs was inhibited by anti-CD1d antibodies and Pru p 3-ligand co-localized with CD1d on epithelial cells. Finally, Pru p 3-ligand presented by CD1d was able to interact with iNKTs. CONCLUSIONS AND CLINICAL RELEVANCE: The Pru p 3 lipid-ligand could act as an adjuvant to promote sensitization to Pru p 3, through its recognition by CD1d receptors. This intrinsic adjuvant activity of the accompanying lipid cargo could be a general essential feature of the mechanism underlying the phenomenon of allergenicity.
Authors: S Jyonouchi; C L Smith; F Saretta; V Abraham; K R Ruymann; P Modayur-Chandramouleeswaran; M-L Wang; J M Spergel; A Cianferoni Journal: Clin Exp Allergy Date: 2014-01 Impact factor: 5.018
Authors: L Tordesillas; C Gómez-Casado; M Garrido-Arandia; A Murua-García; A Palacín; J Varela; P Konieczna; J Cuesta-Herranz; C A Akdis; L O'Mahony; A Díaz-Perales Journal: Clin Exp Allergy Date: 2013-12 Impact factor: 5.018
Authors: Mario Noti; Brian S Kim; Mark C Siracusa; Gregory D Rak; Masato Kubo; Amin E Moghaddam; Quentin A Sattentau; Michael R Comeau; Jonathan M Spergel; David Artis Journal: J Allergy Clin Immunol Date: 2014-02-20 Impact factor: 10.793
Authors: Elisabetta Agea; Anna Russano; Onelia Bistoni; Roberta Mannucci; Ildo Nicoletti; Lanfranco Corazzi; Anthony D Postle; Gennaro De Libero; Steven A Porcelli; Fabrizio Spinozzi Journal: J Exp Med Date: 2005-07-11 Impact factor: 14.307
Authors: Peter A Szabo; Ram V Anantha; Christopher R Shaler; John K McCormick; S M Mansour Haeryfar Journal: Front Immunol Date: 2015-08-12 Impact factor: 7.561
Authors: Silke C Hofmann; Anneleen Bosma; Leena Bruckner-Tuderman; Milica Vukmanovic-Stejic; Elizabeth C Jury; David A Isenberg; Claudia Mauri Journal: J Dermatol Sci Date: 2013-04-19 Impact factor: 4.563
Authors: Svetlana V Guryanova; Ekaterina I Finkina; Daria N Melnikova; Ivan V Bogdanov; Barbara Bohle; Tatiana V Ovchinnikova Journal: Front Mol Biosci Date: 2022-06-16
Authors: Onyinye I Iweala; Shailesh K Choudhary; Claire T Addison; Cole J Batty; Camille M Kapita; Claire Amelio; Alexander J Schuyler; Shenglou Deng; Eric M Bachelder; Kristy M Ainslie; Paul B Savage; Patrick J Brennan; Scott P Commins Journal: J Allergy Clin Immunol Date: 2020-02-20 Impact factor: 10.793
Authors: Isabel J Skypala; Ricardo Asero; Domingo Barber; Lorenzo Cecchi; Arazeli Diaz Perales; Karin Hoffmann-Sommergruber; Elide A Pastorello; Ines Swoboda; Joan Bartra; Didier G Ebo; Margaretha A Faber; Montserrat Fernández-Rivas; Francesca Gomez; Anastasios P Konstantinopoulos; Olga Luengo; Ronald van Ree; Enrico Scala; Stephen J Till Journal: Clin Transl Allergy Date: 2021-05-18 Impact factor: 5.871
Authors: Maksymilian Chruszcz; Fook Tim Chew; Karin Hoffmann-Sommergruber; Barry K Hurlburt; Geoffrey A Mueller; Anna Pomés; Juha Rouvinen; Mayte Villalba; Birgitta M Wöhrl; Heimo Breiteneder Journal: Allergy Date: 2021-05-02 Impact factor: 14.710
Authors: Ivan V Bogdanov; Ekaterina I Finkina; Daria N Melnikova; Rustam H Ziganshin; Tatiana V Ovchinnikova Journal: Nutrients Date: 2021-06-16 Impact factor: 5.717